Corcept Therapeutics (CORT) Current Taxes (2017 - 2018)

Corcept Therapeutics (CORT) reported Current Taxes of $1.6 million for Q3 2018, up 130.42% sequentially from $687000.0 in Q2 2018.

Corcept Therapeutics (CORT) Current Taxes (2017 - 2018) Analysis & Trends

Corcept Therapeutics (CORT) has 2 years of Current Taxes data on file, last reported at $1.6 million in Q3 2018.

For the quarter ending Q3 2018, Current Taxes changed N/A year-over-year to $1.6 million; the trailing twelve-month figure through Sep 2018 stood at $1.6 million (changed N/A YoY), and the FY2017 full-year result was $66000.0, changed N/A from the prior year.
Current Taxes rose to $1.6 million in Q3 2018, from $687000.0 in the prior quarter.
In the past five years, Current Taxes ranged from a high of $1.6 million in Q3 2018 to a low of $66000.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	63.52 Mn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	-
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Corcept Therapeutics	9.99 Bn	9.65 Bn	162.02 Mn	-

Download Data